5-year intensive proof-of-concept trial on therapeutic vaccination (Remune) and intermittent HAART after HAART intensification and GM-CSF use in chronic HIV disease (CTN 140 study)

  • Emil Toma (Invited speaker)
  • M Loignon (Speaker)
  • D Zarowny (Speaker)
  • A Thorne (Speaker)
  • NF Bernard (Speaker)
  • L-G Labrecque (Speaker)
  • C Tremblay (Speaker)
  • L Cyr (Speaker)
  • M-P Cordeau (Speaker)
  • Sindhu, S. (Speaker)
  • José Menezes (Speaker)
  • R Beaulieu (Speaker)

Activity: Talk or presentation types › Oral presentation

Period6 Sep 2005
Event titleAIDS Vaccine 2005 International Conference, Montreal (Canada)
Event typeConference
LocationMontreal, Canada
Degree of RecognitionNational